HALO [@Biotechnology] is valued at $9.53B. HRMY’s [@Biotechnology] market capitalization is $2.2B. The market cap for tickers in the [@Biotechnology] industry ranges from $126.5B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HALO’s FA Score shows that 2 FA rating(s) are green whileHRMY’s FA Score has 1 green FA rating(s).

HALO’s FA Score: 2 green, 3 red.
HRMY’s FA Score: 1 green, 4 red.

According to our system of comparison, HALO is a better buy in the long-term than HRMY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HALO’s TA Score shows that 5 TA indicator(s) are bullish while HRMY’s TA Score has 5 bullish TA indicator(s).

HALO’s TA Score: 5 bullish, 4 bearish.
HRMY’s TA Score: 5 bullish, 4 bearish.

According to our system of comparison, both HALO and HRMY are a good buy in the short-term.

Price Growth

HALO (@Biotechnology) experienced а +5.92% price change this week, while HRMY (@Biotechnology) price change was +6.28% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.57%. For the same industry, the average monthly price growth was +15.43%, and the average quarterly price growth was +1817.75%.

Reported Earning Dates

HALO is expected to report earnings on Aug 11, 2026.

HRMY is expected to report earnings on Aug 11, 2026.

Industries' Descriptions

@Biotechnology (+3.57% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES

FUNDAMENTALS

Fundamentals

HALO($9.53B) has a higher market cap than HRMY($2.21B). HALO has higher P/E ratio than HRMY: HALO (28.19) vs HRMY (15.35). HALO YTD gains are higher at: 21.204 vs. HRMY (2.245). HALO has higher annual earnings (EBITDA): 624M vs. HRMY (237M). HRMY has more cash in the bank: 641M vs. HALO (319M). HRMY has less debt than HALO: HRMY (159M) vs HALO (2.15B). HALO has higher revenues than HRMY: HALO (1.51B) vs HRMY (899M).

	HALO	HRMY	HALO / HRMY
Capitalization	9.53B	2.21B	432%
EBITDA	624M	237M	263%
Gain YTD	21.204	2.245	945%
P/E Ratio	28.19	15.35	184%
Revenue	1.51B	899M	168%
Total Cash	319M	641M	50%
Total Debt	2.15B	159M	1,349%

FUNDAMENTALS RATINGS

HALO vs HRMY: Fundamental Ratings

	HALO	HRMY
OUTLOOK RATING 1..100	31	28
VALUATION overvalued / fair valued / undervalued 1..100	84 Overvalued	69 Overvalued
PROFIT vs RISK RATING 1..100	34	91
SMR RATING 1..100	12	49
PRICE GROWTH RATING 1..100	41	43
P/E GROWTH RATING 1..100	10	30
SEASONALITY SCORE 1..100	50	50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

HRMY's Valuation (69) in the null industry is in the same range as HALO (84) in the Biotechnology industry. This means that HRMY’s stock grew similarly to HALO’s over the last 12 months.

HALO's Profit vs Risk Rating (34) in the Biotechnology industry is somewhat better than the same rating for HRMY (91) in the null industry. This means that HALO’s stock grew somewhat faster than HRMY’s over the last 12 months.

HALO's SMR Rating (12) in the Biotechnology industry is somewhat better than the same rating for HRMY (49) in the null industry. This means that HALO’s stock grew somewhat faster than HRMY’s over the last 12 months.

HALO's Price Growth Rating (41) in the Biotechnology industry is in the same range as HRMY (43) in the null industry. This means that HALO’s stock grew similarly to HRMY’s over the last 12 months.

HALO's P/E Growth Rating (10) in the Biotechnology industry is in the same range as HRMY (30) in the null industry. This means that HALO’s stock grew similarly to HRMY’s over the last 12 months.

TECHNICAL ANALYSIS

Technical Analysis

	HALO	HRMY
RSI ODDS (%)	2 days ago 57%	2 days ago 78%
Stochastic ODDS (%)	2 days ago 61%	2 days ago 70%
Momentum ODDS (%)	2 days ago 71%	2 days ago 71%
MACD ODDS (%)	2 days ago 71%	2 days ago 73%
TrendWeek ODDS (%)	2 days ago 77%	2 days ago 72%
TrendMonth ODDS (%)	2 days ago 75%	2 days ago 73%
Advances ODDS (%)	14 days ago 80%	16 days ago 74%
Declines ODDS (%)	22 days ago 66%	22 days ago 73%
BollingerBands ODDS (%)	2 days ago 60%	2 days ago 78%
Aroon ODDS (%)	2 days ago 74%	2 days ago 76%

View a ticker or compare two or three

Compare

Trend Trader, Long Only: Profitability Model for Russell 2000 Stocks, 60 min, (FA)Trend Trader, Long Only: Profitability Model for Russell 2000 Stocks, 60 min, (FA)

Annualized Return+19%

VIEW DETAILS VIEW DETAILS

VIEW FOR FREE VIEW FOR FREE

Swing Trader for Mid Caps: Comprehensive Intrinsic Sentinel, 60 min, (FA)Swing Trader for Mid Caps: Comprehensive Intrinsic Sentinel, 60 min, (FA)

Annualized Return+20%

VIEW DETAILS VIEW DETAILS

VIEW FOR FREE VIEW FOR FREE

Interact to see
Advertisement

HALO

Setup

Daily Signal:

Description

Gain/Loss:

HRMY

Setup

Daily Signal:

Description

Gain/Loss:

Interesting Tickers

STOCK / NAME	Price $	Chg $	Chg %
		1 Day
ELTK	8.50	N/A	N/A
Eltek Ltd
GSAT	80.11	N/A	N/A
Globalstar Inc
FWRD	13.10	N/A	N/A
Forward Air Corp
CHPGU	10.48	N/A	N/A
Championsgate Acquisition Corp
BRSL	10.89	-0.30	-2.68%
Brightstar Lottery PLC

HALO and

Correlation & Price change

A.I.dvisor indicates that over the last year, HALO has been loosely correlated with AXON. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if HALO jumps, then AXON could also see price increases.

Ticker / NAME	Correlation To HALO	1D Price Change %
HALO	100%	N/A
AXON - HALO	47% Loosely correlated	N/A
INCY - HALO	42% Loosely correlated	N/A
GMAB - HALO	34% Loosely correlated	N/A
VCYT - HALO	34% Loosely correlated	N/A
PHAT - HALO	33% Poorly correlated	N/A
More

HRMY and

Correlation & Price change

A.I.dvisor indicates that over the last year, HRMY has been loosely correlated with ACAD. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if HRMY jumps, then ACAD could also see price increases.

Ticker / NAME	Correlation To HRMY	1D Price Change %
HRMY	100%	N/A
ACAD - HRMY	39% Loosely correlated	N/A
CYTK - HRMY	37% Loosely correlated	N/A
HALO - HRMY	32% Poorly correlated	N/A
AXON - HRMY	31% Poorly correlated	N/A
ORMP - HRMY	30% Poorly correlated	N/A
More